First-line chemotherapy with liposomal doxorubicin plus cisplatin for patients with advanced malignant pleural mesothelioma: phase II trial

Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study

(2011) Tom Treasure et al.   LANCET ONCOLOGY

Chemotherapy and targeted therapies for unresectable malignant mesothelioma

(2011) Ronan Joseph Kelly et al.   LUNG CANCER

Treatment of Malignant Pleural Mesothelioma with Carboplatin, Liposomized Doxorubicin, and Gemcitabine: A Phase II Study

(2010) Gunnar Hillerdal et al.   Journal of Thoracic Oncology

Prognostic Features of Long-term Survivors After Surgical Management of Malignant Pleural Mesothelioma

(2009) Tristan D. Yan et al.   ANNALS OF THORACIC SURGERY

Malignant Pleural Mesothelioma

(2009) Mandira Ray et al.   CHEST

Trimodality Therapy With Induction Chemotherapy Followed by Extrapleural Pneumonectomy and Adjuvant High-Dose Hemithoracic Radiation for Malignant Pleural Mesothelioma

(2009) Marc de Perrot et al.   JOURNAL OF CLINICAL ONCOLOGY

Cisplatin and vinorelbine first-line chemotherapy in non-resectable malignant pleural mesothelioma

(2008) J B Sørensen et al.   BRITISH JOURNAL OF CANCER

Treatment of malignant pleural mesothelioma with liposomized doxorubicine: prolonged time to progression and good survival. A Nordic study

(2008) Gunnar Hillerdal et al.   Clinical Respiratory Journal

Systemic Treatments for Mesothelioma: Standard and Novel

(2008) Hedy Lee Kindler   CURRENT TREATMENT OPTIONS IN ONCOLOGY